Abstract
Cadherins are the transmembrane component of adherens junctions found between interacting cells in tissues. The cadherins bind cells to one another in a specific manner and link to the actin cytoskeleton through intracellular catenins. In addition to promoting strong cell-cell adhesion, cadherins appear to initiate and modify intracellular signaling pathways. The loss of E-cadherin function in epithelial cells is thought to be an important step in tumorigenesis. Moreover, anomalous expression of inappropriate cadherins in epithelial cells alters their behavior and may contribute to the tumorigenic phenotype. For breast cancer the decreased expression of E-cadherin alone may have limited value as a prognostic indicator; however, examining the repertoire of cadherins and catenins expressed by tumors may provide useful prognostic information.
Similar content being viewed by others
REFERENCES
M. Takeichi (1990). Cadherins: A molecular family important in selective cell-cell adhesion. Annu. Rev. Biochem. 59:237-252.
O. W. Blaschuk, S. Munro, and R. Farookhi (1995). Cadherins, steroids and cancer. Endocrine 3:83-89.
M. J. Wheelock, K. A. Knudsen, and K. R. Johnson (1996). Membrane-cytoskeleton interactions with cadherin cell adhesion proteins; roles of catenins as linker proteins. Current Topics in Membranes 43:169-185.
K. A. Knudsen, C. Frankowsky, K. R. Johnson, and M. J. Wheelock (1998). A role for cadherins in cellular signaling and differentiation. J. Cell. Biochem. S 30/31:168-176.
K. R. Johnson, M. J. Wheelock, and M. Takeichi (1999). Cadherins. In T. Kreis and R. Vale (eds.), Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins, Oxford University Press, Oxford, pp. 141-149.
W.-S. Shan, H. Tanaka, G. R. Phillips, K. Arndt, M. Yoshida, D. R. Colman, and L. Shapiro (2000). Functional cisheterodimers of N-and R-cadherins. J. Cell Biol. 148:579-590.
F. S. Walsh and P. Doherty (1997). Neural cell adhesion molecules of the immunoglobulin super family: Role in axonal growth and guidance. Annu. Rev. Cell Biol. 13:425-456.
M. T. Nieman, R. S. Prudoff, K. R. Johnson, and M. J. Wheelock (1999). N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 147:631-643.
R. B. Hazan, G. R. Phillips, R. F. Qiao, L. Norton, and S. A. Aaronson (2000). Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 148:779-790.
J. K. Wahl., P. A. Sacco, T. M. McGranahan, L. Sauppé, M. J. Wheelock, and K. R. Johnson (1996). Plakoglobin domains that define its association with the desmosomal cadherins and the classical cadherins: Identification of unique and shared domains. J. Cell Sci. 109:1043-1054.
J. E. Nieset, A. R. Redfield, F. Jin, K. A. Knudsen, K. R. Johnson, and M. J. Wheelock (1997). Characterization of the interactions of α-catenin with α-actinin and βcatenin/ plakoglobin. J. Cell Sci. 110:1013-1022.
J. M. Daniel, and A. B. Reynolds (1997). Tyrosine phosphorylation and cadherin/catenin function. BioEssays 19:883-891.
J. R. Miller, A. M. Hocking, J. D. Brown, and R. T. Moon (1999). Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2C pathways. Oncogene 18:7860-7872.
K. M. Cadigan and R. Nusse (1997). Wnt signaling: A common theme in animal development. Genes Dev. 11:3286-3305.
P. Polakis, M. Hart, and B. Rubinfeld (1999). Defects in the regulation of beta-catenin in colorectal cancer. Adv. Exp. Med. Biol. 470:23-32.
P. J. Morin. β-catenin signaling and cancer (1999). BioEssays 21:1021-1030.
S. Aono, S. Nakagawa, A. B. Reynolds, and M. Takeichi (1999). p120(ctn) acts as an inhibitory regulator of cadherin function in colon carcinoma cells. J. Cell Biol. 145:551-562.
T. Ohkubo and M. Ozawa (1999). p120(ctn) binds to the membrane-proximal region of the E-cadherin cytoplasmic domain and is involved in modulation of adhesion activity. J. Biol. Chem. 274:21409-21415.
M. A. Thoreson, P. Z. Anastasiadis, J. M. Daniel, R. C. Ireton, M. J. Wheelock, K. R. Johnson, D. K. Hummingbird, and A. B. Reynolds (2000). Selective uncoupling of p120(ctn) from Ecadherin disrupts strong adhesion. J. Cell Biol. 148:189-202.
P. Z. Anastasiadis, S. Y. Moon, M. A. Thoreson, D. J. Mariner, H. C. Crawford, Y. Zheng, and A. B. Reynolds (2000). Inhibition of RhoA by p120 catenin. Nat. Cell Biol. 9:637-644.
N. K. Noren, B. P. Liu, K. Burridge, and B. Kreft (2000). p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J. Cell Biol. 150:567-580.
S. M. Brady-Kalnay and N. K. Tonks (1995). Protein tyrosine phosphatases as adhesion receptors. Curr. Opin. Cell Biol. 7:650-657.
P. Guilford (1999). E-cadherin down-regulation in cancer: Fuel on the fire? Molecular Medicine Today 5:172-177.
J. Behrens (1999). Cadherins and catenins: Role in signal transduction and tumor progression. Cancer and Metastasis Reviews 18:15-30.
M. A. El-Bahrawy, and M. Pignatelli (1998). E-cadherin and catenins: Molecules with versatile roles in normal and neoplastic epithelial cell biology. Microscopy Research and Technique 43:224-232.
A.-K. Perl, P. Wilgenbus, U. Dahl, H. Semb, and G. Christofori (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190-193.
G. Berx, K.-F. Becker, H. Höfler, and F. van Roy (1998). Mutations of the human E-cadherin (CDH1) gene. Human Mutation 12:226-237.
F. Nollet, G., Berx, and F. van Roy (1999). The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol. Bell Biol. Res. Comm. 2:77-85.
M. J. Pishvaian, C. M. Feltes, P. Thompson, M. J. Bussemakers, J. A. Schalken, and S. W. Byers (1999). Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res. 59:947-952.
S. Islam, T. E. Carey, G. T. Wolf, M. J. Wheelock, and K. R. Johnson (1996). Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J. Cell Biol. 135:1643-1654.
J.-B. Kim, S. Islam, Y. J. Kim, R. S. Prudoff, K. M. Sass, M. J. Wheelock, and K. R. Johnson (2000). N-cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J. Cell Biol. 151:1193-1205.
A. Peralta Soler, K. A. Knudsen, M.-C. Jaurand, K. R. Johnson, M. J. Wheelock, A. J. P. Klein-Szanto, and H. Salazar (1995). The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Human Pathology 26:1363-1369.
R. B. Hazan, L. Kang, B. P. Whooley, and P. I. Borgen (1997). N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes. Commun. 4:399-411.
A. S. T. Wong, S. L. Maines-Bandiera, B. Rosen, M. J. Wheelock, K. R. Johnson, P. C. K. Leung, C. D. Roskelley, and N. Auersperg (1999). Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: Influence of family history of ovarian cancer. Int. J. Cancer 81:180-188.
M. Katayama, S. Hirai, K. Kamihagi, K. Nakagawa, M. Yasumoto, and I. Kato (1994). Soluble E-cadherin fragments increased in circulation of cancer patients. Br. J. Cancer 69:580-585.
K. A. Knudsen, Y. L. Chen, K. R. Johnson, M. J. Wheelock, A. A. Keshgegian, and A. Peralta Soler (2000). Lack of correlation between serum levels of E-and P-cadherin fragments and the presence of breast cancer. Human Pathology 31:961-965.
S. Shirahama, F. Furukawa, H. Wakita, and M. Takigawa (1996). E-and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer. J. Dermatol. Sci. 13:30-36.
S. Hiraguri, T. Godfrey, H. Nakamura, J. Graff, C. Collins, L. Shayesteh, N. Doggett, K. R. Johnson, M. J. Wheelock, J. Herman, S. Baylin, D. Pinkel, and J. Gray (1998). Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res. 58:1972-1977.
G. Hennig, J. Behrens, M. Truss, S. Frisch, E. Reichmann, and W. Birchmeier (1995). Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11:475-484.
G. Mbalaviele, C. R. Dunstan, A. Sasaki, P. J. Williams, G. R. Mundy, and T. Yoneda (1996). E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res. 56:4063-4070.
S. Meiners, V. Brinkmann, H. Naundorf, and W. Birchmeier (1998). Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene 16:9-20.
M. E. Bracke, C. Charlier, E. A. Bruyneel, C. Labit, M. M. Mareel, and V. Castronovo (1994). Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res. 54:4607-4609.
S. Z. Yang, N. Kohno, K. Kondo, A. Yokoyama, H. Hamada, K. Hiwada, and M. Miyake (1999). Adriamycin activates Ecadherin-mediated cell-cell adhesion in human breast cancer cells. Int. J. Oncol. 15:1109-1115.
M. E. Bracke, B. M. Vyncke, E. A. Bruyneel, S. J. Vermeulen, G. K. De Bruyne, N. A. Van Larebeke, K. Vleminckx, F. M. Van Roy, and M. M. Mareel (1993). Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Br. J. Cancer. 68:282-289.
Q. Meng, B. Gao, I. D. Goldberg, E. M. Rosen, and S. Fan (2000). Stimulation of cell invasion and migration by alcohol in breast cancer cells. Biochem. Biophys. Res. Commun. 273:448-453.
R. Moll, M. Mitze, U. H. Frixen, and W. Birchmeier (1993). Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol. 143:1731-1742.
C. Gamallo, J. Palacios, A. Suarez, A. Pizarro, P. Navarro, M. Quintanilla, and A. Cano (1993). Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am. J. Pathol. 142:987-993.
S. A. Rasbridge, C. E. Gillett, S. A. Sampson, F. S. Walsh, and R. R. Millis (1993). Epithelial (E-) and Placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J. Pathol. 169:245-250.
S. M. Siitonen, J. T. Kononen, H. J. Helin, I. S. Rantala, K. A. Holli, and J. J. Isola (1996). Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol. 105:394-402.
W. J. De Leeuw, G. Berx, C. B. Vos, J. L. Peterse, M. J. Van de Vijver, S. Litvinov, F. Van Roy, C. J. Cornelisse, and A. M. Cleton-Jansen (1997). Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J. Pathol. 183:404-411.
C. B. Vos, A. M. Cleton-Jansen, G. Berx, W. J. de Leeuw, N. T. ter Haar, F. van Roy, C. J. Cornelisse, J. L. Peterse, and M. J. van de Vijver (1997). E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br. J. Cancer 76:1131-1133.
G. Keller, H. Vogelsang, I. Becker, J. Hutter, K. Ott, S. Candidus, T. Grundei, K. F. Becker, J. Mueller, J. R. Siewert, and H. Hofler (1999). Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am. J. Pathol. 155:337-342.
R. Hashizume, H. Koizumi, A. Ihara, T. Ohta, and T. Uchikoshi (1996). Expression of β-catenin in normal breast tissue and breast carcinoma: A comparative study with epithelial cadherin and β-catenin. Histopathology 29:139-146.
A. Peralta Soler, K. A. Knudsen, H. Salazar, A. C. Han, and A. A. Keshgegian (1999). P-cadherin expression in breast carcinoma indicates poor survival. Cancer 86:1263-1272.
H. Oka, H. Shiozaki, K. Kobayashi, M. Inoue, H. Tahara, T. Kobayashi, Y. Takatsuka, N. Matsuyoshi, S. Hirano, M. Takeichi, and T. Mori (1993). Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 53:1696-1701.
S. K. Gupta, A. G. Douglas-Jones, B. Jasani, J. M. Morgan, M. Pignatelli, and R. E. Mansel (1997). E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast. Virchows Arch. 430:23-28.
C. Charpin, S. Garcia, C. Bouvier, B. Devictor, L. Andrac, R. Choux, and M. Lavaut (1997). E-cadherin quantitative immunocytochemical assays in breast carcinomas. J. Pathol. 181:294-300.
W. Zschiesche, I. Schonborn, J. Behrens, K. Herrenknecht, F. Hartveit, P. Lilleng, and W. Birchmeier (1997). Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res. 17:561-567.
J. L. Jones, J. E. Royall, and R. A. Walker (1996). E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Br. J. Cancer. 74:1237-1241.
I. K. Bukholm, J. M. Nesland, and A. L. Borresen-Dale (2000). Re-expression of E-cadherin, α-catenin, and β-catenin, but not of γ-catenin, in tissue from breast cancer patients. J. Pathol. 190:15-19.
I. Funke, S. Fries, M. Rolle, M. M. Heiss, M. Untch, H. Bohmert, F. W. Schildberg, and K. W. Jauch (1996). Comparative analysis of bone marrow micrometastases in breast and gastric cancer. Int. J. Cancer. 65:755-761.
G. P. Cowley and M. E. Smith (1995). Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int. J. Cancer 60:325-329.
J. R. Graff, E. Gabrielson, H. Fujii, S. B. Baylin, and J. G. Herman (2000). Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J. Biol. Chem. 275:2727-2732.
C. Charpin, S. Garcia, P. Bonnier, F. Martini, L. Andrac, R. Choux, M. N. Lavaut, and C. Allasia (1998). Reduced Ecadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. Am. J. Clin. Pathol. 109:431-438.
T. M. Maguire, S. G. Shering, E. W. McDermott, N. O'Higgins, J. J. Fennelly, J. Crown, and M. J. Duffy (1997). Assay of E-cadherin by ELISA in human breast cancers. Eur. J. Cancer 33:404-408.
R. Heimann, F. Lan, R. McBride, and S. Hellman (2000). Separating favorable from unfavorable prognostic markers in breast cancer: The role of E-cadherin. Cancer Res. 60:298-304.
K. S. Asgeirsson, J. G. Jonasson, L. Tryggvadottir, K. Olafsdottir, J. R. Sigurgeirsdottir, S. Invarsson, and H. M. Ogmundsdottir (2000). Altered expression of E-cadherin in breast cancer: Patterns, mechanisms and clinical significance. Eur. J. Cancer. 36:1098-1106.
P. Lipponen, E. Saarelainen, S. Aaltomaa, and K. Syrjanen (1994). Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J. Pathol. 174:101-109.
M. A. Gonzalez, S. E. Pinder, P. M. Wencyk, J. A. Bell, C. W. Elston, R. I. Nicholson, J. F. Robertson, R. W. Blamey, and I. O. Ellis (1999). An immunohistochemical examination of the expression of E-cadherin, α-and β/γ-catenins, and α2-and β1-integrins in invasive breast cancer. J. Pathol. 187:523-529.
D. S. Tan, H. W. Potts, A. C. Leong, D. Skilton, W. H. Harris, R. D. Liebmann, and A. M. Hanby (1999). The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast. J. Pathol. 189:20-27.
D. L. Rimm, J. H. Sinard, and J. S. Morrow (1995). Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab Invest. 72:506-512.
I. K. Bukholm, J. M. Nesland, R. Karesen, U. Jacobsen, and A. L. Borresen-Dale (1998). E-cadherin and α-, β-, and γ-catenin protein expression in relation to metastasis in human breast carcinoma. J. Pathol. 185:262-266.
J. M. Williams and C. W. Daniel (1983). Mammary ductal elongation: Differentiation of myoepithelium and basal lamina during branching morphogenesis. Devlop. Biol. 97:274-290.
J. Palacios, N. Benito, A. Pizarro, A. Suarez, J. Espada, A. Cano, and C. Gamallo (1995). Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am. J. Pathol. 146:605-612.
G. Kremmidiotis, E. Baker, J. Crawford, H. J. Eyre, J. Nahmias, and D. F. Callen (1998). Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics 49:467-471.
S. W. Lee (1996). H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat. Med. 2:776-782.
S. W. Lee, C. L. Reimer, D. B. Campbell, P. Cheresh, R. B. Duda, and O. Kocher (1998). H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis 19:1157-1159.
C. L. Sommers, E. P. Gelmann, R. Kemler, P. Cowin, and S. W. Byers (1994). Alterations in β-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res. 54:3544-3552.